• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可适应的无创产前检测模型参数可带来更稳定的预测结果。

Adaptable Model Parameters in Non-Invasive Prenatal Testing Lead to More Stable Predictions.

机构信息

Geneton Ltd., Bratislava 841 04, Slovakia.

Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava 841 04, Slovakia.

出版信息

Int J Mol Sci. 2019 Jul 11;20(14):3414. doi: 10.3390/ijms20143414.

DOI:10.3390/ijms20143414
PMID:31336782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6678500/
Abstract

Recent advances in massively parallel shotgun sequencing opened up new options for affordable non-invasive prenatal testing (NIPT) for fetus aneuploidy from DNA material extracted from maternal plasma. Tests typically compare chromosomal distributions of a tested sample with a control set of healthy samples with unaffected fetuses. Deviations above certain threshold levels are concluded as positive findings. The main problem with this approach is that the variance of the control set is dependent on the number of sequenced fragments. The higher the amount, the more precise the estimation of actual chromosomal proportions is. Testing a sample with a highly different number of sequenced reads as used in training may thus lead to over- or under-estimation of their variance, and so lead to false predictions. We propose the calculation of a variance for each tested sample adaptively, based on the actual number of its sequenced fragments. We demonstrate how it leads to more stable predictions, mainly in real-world diagnostics with the highly divergent inter-sample coverage.

摘要

近年来,大规模平行 shotgun 测序技术的发展为从母体血浆中提取的 DNA 物质进行负担得起的非侵入性产前检测(NIPT)提供了新的选择,以检测胎儿非整倍体。这些测试通常将测试样本的染色体分布与一组包含正常胎儿的健康样本的控制集进行比较。超过一定阈值水平的偏差被认为是阳性发现。这种方法的主要问题是,控制集的方差取决于测序片段的数量。数量越高,对实际染色体比例的估计就越精确。因此,用训练中使用的高度不同的测序reads 数量来测试一个样本可能会导致对其方差的过高或过低估计,从而导致错误的预测。我们建议根据实际的测序片段数量,为每个测试样本自适应地计算方差。我们展示了它如何导致更稳定的预测,特别是在具有高度不同的样本间覆盖度的现实世界诊断中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/5044f845236d/ijms-20-03414-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/dbf7f2dd30b9/ijms-20-03414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/48be16f5f7b4/ijms-20-03414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/87dea0e8ca14/ijms-20-03414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/73bdefbfc2d2/ijms-20-03414-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/5044f845236d/ijms-20-03414-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/dbf7f2dd30b9/ijms-20-03414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/48be16f5f7b4/ijms-20-03414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/87dea0e8ca14/ijms-20-03414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/73bdefbfc2d2/ijms-20-03414-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/6678500/5044f845236d/ijms-20-03414-g005.jpg

相似文献

1
Adaptable Model Parameters in Non-Invasive Prenatal Testing Lead to More Stable Predictions.可适应的无创产前检测模型参数可带来更稳定的预测结果。
Int J Mol Sci. 2019 Jul 11;20(14):3414. doi: 10.3390/ijms20143414.
2
Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.通过对静脉穿刺后长达 24 小时的母体血浆中循环游离 DNA 进行大规模平行测序,实现可靠的无创性产前检测。
Clin Biochem. 2013 Dec;46(18):1783-6. doi: 10.1016/j.clinbiochem.2013.07.020. Epub 2013 Aug 8.
3
Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.用于产前检测的母血血浆DNA和RNA测序
Adv Clin Chem. 2016;74:63-102. doi: 10.1016/bs.acc.2015.12.004. Epub 2016 Jan 21.
4
Development of Reference Materials for Noninvasive Prenatal Aneuploidy Testing by Massively Parallel Sequencing: A Proof-of-Concept Study.基于大规模平行测序的无创产前非整倍体检测参考物质的开发:概念验证研究
J Appl Lab Med. 2019 Jul;4(1):50-60. doi: 10.1373/jalm.2018.028100. Epub 2019 Mar 1.
5
Non-invasive prenatal aneuploidy testing: Critical diagnostic performance parameters predict sample z-score values.无创产前非整倍体检测:关键诊断性能参数可预测样本Z分数值。
Clin Biochem. 2018 Sep;59:69-77. doi: 10.1016/j.clinbiochem.2018.06.015. Epub 2018 Jun 27.
6
[Application of next-generation DNA sequencing for prenatal testing of fetal chromosomal aneuploidies].[下一代DNA测序在胎儿染色体非整倍体产前检测中的应用]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Aug;32(4):533-7. doi: 10.3760/cma.j.issn.1003-9406.2015.04.019.
7
Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.鉴定母体游离 DNA 中未修饰和 5-羟甲基化 CG 位点,用于无创性产前检测。
Clin Epigenetics. 2020 Oct 20;12(1):153. doi: 10.1186/s13148-020-00938-x.
8
Combination of Fetal Fraction Estimators Based on Fragment Lengths and Fragment Counts in Non-Invasive Prenatal Testing.基于片段长度和片段计数的非侵入性产前检测中胎儿分数估算器的联合应用。
Int J Mol Sci. 2019 Aug 14;20(16):3959. doi: 10.3390/ijms20163959.
9
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
10
Non invasive prenatal testing (NIPT) for common aneuploidies and beyond.用于常见非整倍体及其他情况的无创产前检测(NIPT)。
Eur J Obstet Gynecol Reprod Biol. 2021 Mar;258:424-429. doi: 10.1016/j.ejogrb.2021.01.008. Epub 2021 Jan 19.

引用本文的文献

1
Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing.端粒长度作为无创产前检测中胎儿分数预测的生物标志物。
PLoS One. 2025 Jul 11;20(7):e0327714. doi: 10.1371/journal.pone.0327714. eCollection 2025.
2
Understanding genetic variability: exploring large-scale copy number variants through non-invasive prenatal testing in European populations.理解遗传变异性:通过欧洲人群的非侵入性产前检测探索大规模拷贝数变异。
BMC Genomics. 2024 Apr 15;25(1):366. doi: 10.1186/s12864-024-10267-5.
3
Insights into non-informative results from non-invasive prenatal screening through gestational age, maternal BMI, and age analyses.

本文引用的文献

1
Non-invasive prenatal testing as a valuable source of population specific allelic frequencies.非侵入性产前检测作为一种有价值的群体特异性等位基因频率来源。
J Biotechnol. 2019 Jun 20;299:72-78. doi: 10.1016/j.jbiotec.2019.04.026. Epub 2019 May 1.
2
Combining count- and length-based z-scores leads to improved predictions in non-invasive prenatal testing.基于计数和长度的 Z 分数相结合可提高非侵入性产前检测的预测效果。
Bioinformatics. 2019 Apr 15;35(8):1284-1291. doi: 10.1093/bioinformatics/bty806.
3
The importance of determining the limit of detection of non-invasive prenatal testing methods.
通过对孕龄、母体 BMI 和年龄进行分析,深入了解非侵入性产前筛查的非信息性结果。
PLoS One. 2024 Mar 7;19(3):e0280858. doi: 10.1371/journal.pone.0280858. eCollection 2024.
4
Evaluation and limitations of different approaches among COVID-19 fatal cases using whole-exome sequencing data.利用全外显子组测序数据评估和比较 COVID-19 死亡病例的不同方法。
BMC Genomics. 2023 Jan 10;24(1):12. doi: 10.1186/s12864-022-09084-5.
5
Copy Number Variant Detection with Low-Coverage Whole-Genome Sequencing Represents a Viable Alternative to the Conventional Array-CGH.利用低覆盖度全基因组测序进行拷贝数变异检测是传统阵列比较基因组杂交的可行替代方法。
Diagnostics (Basel). 2021 Apr 15;11(4):708. doi: 10.3390/diagnostics11040708.
6
Prenatal genetic diagnosis: Fetal therapy as a possible solution to a positive test.产前基因诊断:胎儿治疗作为阳性检测的可能解决方案。
Acta Biomed. 2020 Nov 9;91(13-S):e2020021. doi: 10.23750/abm.v91i13-S.10534.
7
Cell-Free Nucleic Acids.无细胞核酸。
Int J Mol Sci. 2019 Nov 12;20(22):5645. doi: 10.3390/ijms20225645.
确定无创产前检测方法检测限的重要性。
Prenat Diagn. 2016 Apr;36(4):304-11. doi: 10.1002/pd.4780. Epub 2016 Feb 21.
4
Utilization of Benchtop Next Generation Sequencing Platforms Ion Torrent PGM and MiSeq in Noninvasive Prenatal Testing for Chromosome 21 Trisomy and Testing of Impact of In Silico and Physical Size Selection on Its Analytical Performance.台式下一代测序平台Ion Torrent PGM和MiSeq在21三体染色体无创产前检测中的应用以及电子模拟和物理大小选择对其分析性能的影响测试
PLoS One. 2015 Dec 15;10(12):e0144811. doi: 10.1371/journal.pone.0144811. eCollection 2015.
5
Application of risk score analysis to low-coverage whole genome sequencing data for the noninvasive detection of trisomy 21, trisomy 18, and trisomy 13.风险评分分析在低覆盖度全基因组测序数据中用于无创检测21三体、18三体和13三体的应用。
Prenat Diagn. 2016 Jan;36(1):56-62. doi: 10.1002/pd.4712. Epub 2015 Dec 23.
6
Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma.通过对母血中循环游离DNA进行测序检测胎儿亚染色体异常。
Clin Chem. 2015 Apr;61(4):608-16. doi: 10.1373/clinchem.2014.233312. Epub 2015 Feb 20.
7
Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.基于大小的分子诊断技术,利用血浆 DNA 进行无创性产前检测。
Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8583-8. doi: 10.1073/pnas.1406103111. Epub 2014 May 19.
8
Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing.应用半导体测序技术进行常见非整倍体的无创性产前诊断。
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7415-20. doi: 10.1073/pnas.1321997111. Epub 2014 May 5.
9
WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme.WISECONDOR:基于样本内比较方案的从浅层测序母体外周血浆中检测胎儿异常。
Nucleic Acids Res. 2014 Mar;42(5):e31. doi: 10.1093/nar/gkt992. Epub 2013 Oct 28.
10
Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.基于母体外周血游离 DNA 测序的全基因组胎儿非整倍体检测
Obstet Gynecol. 2012 May;119(5):890-901. doi: 10.1097/AOG.0b013e31824fb482.